Truist Financial Corp Invitae Corp Transaction History

Truist Financial Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$2.13 - $9.01 $46,964 - $198,661	-22,049 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$6.28 - $15.59 $5,495 - $13,641	-875 Reduced 3.82%	22,049 $176,000
Q4 2021 Feb 14, 2022	SELL	$14.7 - $28.67 $55,169 - $107,598	-3,753 Reduced 14.07%	22,924 $350,000
Q3 2021 Nov 05, 2021	BUY	$24.31 - $33.6 $453,673 - $627,043	18,662 Added 232.84%	26,677 $759,000
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $81,113 - $125,603	-3,109 Reduced 27.95%	8,015 $270,000
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $165,200 - $284,479	4,997 Added 81.56%	11,124 $425,000
Q4 2020 Nov 19, 2021	SELL	$39.09 - $57.4 $324,564 - $476,592	-8,303 Reduced 57.54%	6,127 $256,000
Q4 2020 Feb 18, 2021	BUY	$39.09 - $57.4 $110,741 - $162,614	2,833 Added 24.43%	14,430 $603,000
Q3 2020 Nov 13, 2020	BUY	$28.43 - $44.67 $329,702 - $518,037	11,597 New	11,597 $503,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.